世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 ランレオチドの世界市場に関する洞察と2028年までの予測Global Lanreotide Market Insights and Forecast to 2028 Lanreotide（INN）は、先端巨大症と神経内分泌腫瘍（特にカルチノイド症候群）による症状の管理に使用される医薬品です 市場の分析と洞察。ランレオチドの世界市場 COVID-19の流行により、世界のランレオチド市... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーLanreotide（INN）は、先端巨大症と神経内分泌腫瘍（特にカルチノイド症候群）による症状の管理に使用される医薬品です市場の分析と洞察。ランレオチドの世界市場 COVID-19の流行により、世界のランレオチド市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年にランレオチド世界市場の％を占める60mgは、2028年までに100万米ドルの価値を持ち、ポストCOVID-19期間に修正された％のCAGRで成長すると予測されています。一方、病院セグメントは、この予測期間を通して％CAGRに変更されています。 2021年の中国ランレオチド市場規模は百万米ドル、米国と欧州ランレオチドはそれぞれ百万米ドル、百万米ドルと評価されています。2021年の米国の割合は％、中国とヨーロッパはそれぞれ％と％で、中国の割合は2028年に％に達すると予測され、分析期間を通じてCAGRは％となります。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパのランレオチド市場については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。 Lanreotideの世界的な主要メーカーには、IPSEN社などがあります。2021年には、世界の上位5社が売上高で約 %のシェアを獲得しています。 世界のランレオタイドの範囲とセグメント ランレオチド市場は、タイプ別および用途別に分類されます。世界のLanreotide市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。 タイプ別セグメント 60mg 90mg 120mg 用途別セグメント 病院 薬局 会社別 イプセン 地域別 北アメリカ 米国 カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジア太平洋地域 中国 日本 韓国 インド オーストラリア 中国 台湾 インドネシア タイ マレーシア 中南米 メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア UAE 目次1 Study Coverage1.1 Lanreotide Product Introduction 1.2 Market by Type 1.2.1 Global Lanreotide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 60 mg 1.2.3 90 mg 1.2.4 120 mg 1.3 Market by Application 1.3.1 Global Lanreotide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Lanreotide Sales Estimates and Forecasts 2017-2028 2.2 Global Lanreotide Revenue Estimates and Forecasts 2017-2028 2.3 Global Lanreotide Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Lanreotide Sales by Region 2.4.1 Global Lanreotide Sales by Region (2017-2022) 2.4.2 Global Sales Lanreotide by Region (2023-2028) 2.5 Global Lanreotide Revenue by Region 2.5.1 Global Lanreotide Revenue by Region (2017-2022) 2.5.2 Global Lanreotide Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Lanreotide Sales by Manufacturers 3.1.1 Global Top Lanreotide Manufacturers by Sales (2017-2022) 3.1.2 Global Lanreotide Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lanreotide in 2021 3.2 Global Lanreotide Revenue by Manufacturers 3.2.1 Global Lanreotide Revenue by Manufacturers (2017-2022) 3.2.2 Global Lanreotide Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Lanreotide Revenue in 2021 3.3 Global Lanreotide Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Lanreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Lanreotide Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Lanreotide Sales by Type 4.1.1 Global Lanreotide Historical Sales by Type (2017-2022) 4.1.2 Global Lanreotide Forecasted Sales by Type (2023-2028) 4.1.3 Global Lanreotide Sales Market Share by Type (2017-2028) 4.2 Global Lanreotide Revenue by Type 4.2.1 Global Lanreotide Historical Revenue by Type (2017-2022) 4.2.2 Global Lanreotide Forecasted Revenue by Type (2023-2028) 4.2.3 Global Lanreotide Revenue Market Share by Type (2017-2028) 4.3 Global Lanreotide Price by Type 4.3.1 Global Lanreotide Price by Type (2017-2022) 4.3.2 Global Lanreotide Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Lanreotide Sales by Application 5.1.1 Global Lanreotide Historical Sales by Application (2017-2022) 5.1.2 Global Lanreotide Forecasted Sales by Application (2023-2028) 5.1.3 Global Lanreotide Sales Market Share by Application (2017-2028) 5.2 Global Lanreotide Revenue by Application 5.2.1 Global Lanreotide Historical Revenue by Application (2017-2022) 5.2.2 Global Lanreotide Forecasted Revenue by Application (2023-2028) 5.2.3 Global Lanreotide Revenue Market Share by Application (2017-2028) 5.3 Global Lanreotide Price by Application 5.3.1 Global Lanreotide Price by Application (2017-2022) 5.3.2 Global Lanreotide Price Forecast by Application (2023-2028) 6 North America 6.1 North America Lanreotide Market Size by Type 6.1.1 North America Lanreotide Sales by Type (2017-2028) 6.1.2 North America Lanreotide Revenue by Type (2017-2028) 6.2 North America Lanreotide Market Size by Application 6.2.1 North America Lanreotide Sales by Application (2017-2028) 6.2.2 North America Lanreotide Revenue by Application (2017-2028) 6.3 North America Lanreotide Market Size by Country 6.3.1 North America Lanreotide Sales by Country (2017-2028) 6.3.2 North America Lanreotide Revenue by Country (2017-2028) 6.3.3 the United States 6.3.4 Canada 7 Europe 7.1 Europe Lanreotide Market Size by Type 7.1.1 Europe Lanreotide Sales by Type (2017-2028) 7.1.2 Europe Lanreotide Revenue by Type (2017-2028) 7.2 Europe Lanreotide Market Size by Application 7.2.1 Europe Lanreotide Sales by Application (2017-2028) 7.2.2 Europe Lanreotide Revenue by Application (2017-2028) 7.3 Europe Lanreotide Market Size by Country 7.3.1 Europe Lanreotide Sales by Country (2017-2028) 7.3.2 Europe Lanreotide Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 UK 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Lanreotide Market Size by Type 8.1.1 Asia Pacific Lanreotide Sales by Type (2017-2028) 8.1.2 Asia Pacific Lanreotide Revenue by Type (2017-2028) 8.2 Asia Pacific Lanreotide Market Size by Application 8.2.1 Asia Pacific Lanreotide Sales by Application (2017-2028) 8.2.2 Asia Pacific Lanreotide Revenue by Application (2017-2028) 8.3 Asia Pacific Lanreotide Market Size by Region 8.3.1 Asia Pacific Lanreotide Sales by Region (2017-2028) 8.3.2 Asia Pacific Lanreotide Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Lanreotide Market Size by Type 9.1.1 Latin America Lanreotide Sales by Type (2017-2028) 9.1.2 Latin America Lanreotide Revenue by Type (2017-2028) 9.2 Latin America Lanreotide Market Size by Application 9.2.1 Latin America Lanreotide Sales by Application (2017-2028) 9.2.2 Latin America Lanreotide Revenue by Application (2017-2028) 9.3 Latin America Lanreotide Market Size by Country 9.3.1 Latin America Lanreotide Sales by Country (2017-2028) 9.3.2 Latin America Lanreotide Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Lanreotide Market Size by Type 10.1.1 Middle East and Africa Lanreotide Sales by Type (2017-2028) 10.1.2 Middle East and Africa Lanreotide Revenue by Type (2017-2028) 10.2 Middle East and Africa Lanreotide Market Size by Application 10.2.1 Middle East and Africa Lanreotide Sales by Application (2017-2028) 10.2.2 Middle East and Africa Lanreotide Revenue by Application (2017-2028) 10.3 Middle East and Africa Lanreotide Market Size by Country 10.3.1 Middle East and Africa Lanreotide Sales by Country (2017-2028) 10.3.2 Middle East and Africa Lanreotide Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 IPSEN 11.1.1 IPSEN Corporation Information 11.1.2 IPSEN Overview 11.1.3 IPSEN Lanreotide Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 IPSEN Lanreotide Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 IPSEN Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Lanreotide Industry Chain Analysis 12.2 Lanreotide Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Lanreotide Production Mode & Process 12.4 Lanreotide Sales and Marketing 12.4.1 Lanreotide Sales Channels 12.4.2 Lanreotide Distributors 12.5 Lanreotide Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Lanreotide Industry Trends 13.2 Lanreotide Market Drivers 13.3 Lanreotide Market Challenges 13.4 Lanreotide Market Restraints 14 Key Findings in The Global Lanreotide Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryLanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome Table of Contents1 Study Coverage1.1 Lanreotide Product Introduction 1.2 Market by Type 1.2.1 Global Lanreotide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 60 mg 1.2.3 90 mg 1.2.4 120 mg 1.3 Market by Application 1.3.1 Global Lanreotide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Lanreotide Sales Estimates and Forecasts 2017-2028 2.2 Global Lanreotide Revenue Estimates and Forecasts 2017-2028 2.3 Global Lanreotide Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Lanreotide Sales by Region 2.4.1 Global Lanreotide Sales by Region (2017-2022) 2.4.2 Global Sales Lanreotide by Region (2023-2028) 2.5 Global Lanreotide Revenue by Region 2.5.1 Global Lanreotide Revenue by Region (2017-2022) 2.5.2 Global Lanreotide Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Lanreotide Sales by Manufacturers 3.1.1 Global Top Lanreotide Manufacturers by Sales (2017-2022) 3.1.2 Global Lanreotide Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lanreotide in 2021 3.2 Global Lanreotide Revenue by Manufacturers 3.2.1 Global Lanreotide Revenue by Manufacturers (2017-2022) 3.2.2 Global Lanreotide Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Lanreotide Revenue in 2021 3.3 Global Lanreotide Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Lanreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Lanreotide Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Lanreotide Sales by Type 4.1.1 Global Lanreotide Historical Sales by Type (2017-2022) 4.1.2 Global Lanreotide Forecasted Sales by Type (2023-2028) 4.1.3 Global Lanreotide Sales Market Share by Type (2017-2028) 4.2 Global Lanreotide Revenue by Type 4.2.1 Global Lanreotide Historical Revenue by Type (2017-2022) 4.2.2 Global Lanreotide Forecasted Revenue by Type (2023-2028) 4.2.3 Global Lanreotide Revenue Market Share by Type (2017-2028) 4.3 Global Lanreotide Price by Type 4.3.1 Global Lanreotide Price by Type (2017-2022) 4.3.2 Global Lanreotide Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Lanreotide Sales by Application 5.1.1 Global Lanreotide Historical Sales by Application (2017-2022) 5.1.2 Global Lanreotide Forecasted Sales by Application (2023-2028) 5.1.3 Global Lanreotide Sales Market Share by Application (2017-2028) 5.2 Global Lanreotide Revenue by Application 5.2.1 Global Lanreotide Historical Revenue by Application (2017-2022) 5.2.2 Global Lanreotide Forecasted Revenue by Application (2023-2028) 5.2.3 Global Lanreotide Revenue Market Share by Application (2017-2028) 5.3 Global Lanreotide Price by Application 5.3.1 Global Lanreotide Price by Application (2017-2022) 5.3.2 Global Lanreotide Price Forecast by Application (2023-2028) 6 North America 6.1 North America Lanreotide Market Size by Type 6.1.1 North America Lanreotide Sales by Type (2017-2028) 6.1.2 North America Lanreotide Revenue by Type (2017-2028) 6.2 North America Lanreotide Market Size by Application 6.2.1 North America Lanreotide Sales by Application (2017-2028) 6.2.2 North America Lanreotide Revenue by Application (2017-2028) 6.3 North America Lanreotide Market Size by Country 6.3.1 North America Lanreotide Sales by Country (2017-2028) 6.3.2 North America Lanreotide Revenue by Country (2017-2028) 6.3.3 the United States 6.3.4 Canada 7 Europe 7.1 Europe Lanreotide Market Size by Type 7.1.1 Europe Lanreotide Sales by Type (2017-2028) 7.1.2 Europe Lanreotide Revenue by Type (2017-2028) 7.2 Europe Lanreotide Market Size by Application 7.2.1 Europe Lanreotide Sales by Application (2017-2028) 7.2.2 Europe Lanreotide Revenue by Application (2017-2028) 7.3 Europe Lanreotide Market Size by Country 7.3.1 Europe Lanreotide Sales by Country (2017-2028) 7.3.2 Europe Lanreotide Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 UK 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Lanreotide Market Size by Type 8.1.1 Asia Pacific Lanreotide Sales by Type (2017-2028) 8.1.2 Asia Pacific Lanreotide Revenue by Type (2017-2028) 8.2 Asia Pacific Lanreotide Market Size by Application 8.2.1 Asia Pacific Lanreotide Sales by Application (2017-2028) 8.2.2 Asia Pacific Lanreotide Revenue by Application (2017-2028) 8.3 Asia Pacific Lanreotide Market Size by Region 8.3.1 Asia Pacific Lanreotide Sales by Region (2017-2028) 8.3.2 Asia Pacific Lanreotide Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Lanreotide Market Size by Type 9.1.1 Latin America Lanreotide Sales by Type (2017-2028) 9.1.2 Latin America Lanreotide Revenue by Type (2017-2028) 9.2 Latin America Lanreotide Market Size by Application 9.2.1 Latin America Lanreotide Sales by Application (2017-2028) 9.2.2 Latin America Lanreotide Revenue by Application (2017-2028) 9.3 Latin America Lanreotide Market Size by Country 9.3.1 Latin America Lanreotide Sales by Country (2017-2028) 9.3.2 Latin America Lanreotide Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Lanreotide Market Size by Type 10.1.1 Middle East and Africa Lanreotide Sales by Type (2017-2028) 10.1.2 Middle East and Africa Lanreotide Revenue by Type (2017-2028) 10.2 Middle East and Africa Lanreotide Market Size by Application 10.2.1 Middle East and Africa Lanreotide Sales by Application (2017-2028) 10.2.2 Middle East and Africa Lanreotide Revenue by Application (2017-2028) 10.3 Middle East and Africa Lanreotide Market Size by Country 10.3.1 Middle East and Africa Lanreotide Sales by Country (2017-2028) 10.3.2 Middle East and Africa Lanreotide Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 IPSEN 11.1.1 IPSEN Corporation Information 11.1.2 IPSEN Overview 11.1.3 IPSEN Lanreotide Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 IPSEN Lanreotide Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 IPSEN Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Lanreotide Industry Chain Analysis 12.2 Lanreotide Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Lanreotide Production Mode & Process 12.4 Lanreotide Sales and Marketing 12.4.1 Lanreotide Sales Channels 12.4.2 Lanreotide Distributors 12.5 Lanreotide Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Lanreotide Industry Trends 13.2 Lanreotide Market Drivers 13.3 Lanreotide Market Challenges 13.4 Lanreotide Market Restraints 14 Key Findings in The Global Lanreotide Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
